AbbVie Inc. (0QCV.IL)

162,40 +0,82 (+0,51%) Ab 07:14PM BST. Markt geöffnet.

AbbVie Inc.

1 North Waukegan Road
North Chicago, IL 60064-6400
United States
847 932 7900
https://www.abbvie.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - General
Vollzeitmitarbeiter: 50.000

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Richard A. Gonzalez	Chairman & CEO	6,95M	N/A	1954
Mr. Robert A. Michael	Pres & COO	4M	N/A	1970
Mr. Scott T. Reents	Exec. VP & CFO	2,97M	N/A	1968
Dr. Azita Saleki-Gerhardt Ph.D.	Exec. VP & COO	2,58M	N/A	1963
Mr. Jeffrey Ryan Stewart	Exec. VP & Chief Commercial Officer	2,98M	2,78M	1969
Dr. Thomas J. Hudson M.D.	Sr. VP of R&D and Chief Scientific Officer	N/A	N/A	1962
Ms. Elizabeth Shea	Sr. VP of Investor Relations	N/A	N/A	N/A
Mr. Sanjay Narayan	VP, Chief Ethics & Compliance Officer	N/A	N/A	N/A
Ms. Tracie Haas	Sr. VP of Corp. Responsibility, Brand & Communications	N/A	N/A	N/A
Mr. Timothy J. Richmond	Exec. VP & Chief HR Officer	N/A	N/A	1966

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; and California Institute for Biomedical Research (Calibr). The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Corporate Governance

AbbVie Inc.s ISS Governance QualityScore, Stand 1. Oktober 2023, lautet 9. Die grundlegenden Scores sind Audit: 9, Vorstand: 7, Shareholderrechte: 9, Kompensation: 7.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.